Literature DB >> 28343557

Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.

Susan B Brogly1, Suzanne Turner2, Katherine Lajkosz3, Greg Davies4, Adam Newman5, Ana Johnson6, Kimberly Dow7.   

Abstract

BACKGROUND: There is a paucity of data characterizing mother-infant pairs with prenatal opioid dependence in Canada. We therefore conducted a study of relevant births in Ontario from 2002 to 2014.
METHODS: We used data from the Institute for Clinical Evaluative Sciences, the linked databases of coded population-based Ontario health services records. Differences in characteristics of opioid-dependent mother-neonate pairs and infant hospital costs by year were assessed using linear regression, and we calculated rates of preterm birth, low birth weight, birth defects, mortality, and neonatal abstinence syndrome.
RESULTS: The number of infants born to opioid-dependent women in Ontario rose from 46 in 2002 to almost 800 in 2014. Methadone was most frequently used for prenatal opioid dependence; there was little buprenorphine or buprenorphine + naloxone use. Rates of preterm birth and low birth weight were high. The proportion of neonates with neonatal abstinence syndrome (58%) was stable over the study period. The mean length of neonatal hospital stay was 13.96 days. Infant hospital costs increased from $724 774 in 2003 to $10 539 988 in 2013, and the mean cost per infant grew from $9928 to $12 917. Birth defect prevalence was 75.84/1000 live births (95% CI 68.12/1000 to 84.10/1000). The stillbirth rate was 11.39/1000 births (95% CI 8.47/1000 to 14.99/1000), and the infant mortality rate was 12.21/1000 live births (95% CI 9.16/1000 to 15.95/1000).
CONCLUSION: We observed a 16-fold increase in the number of mother-infant pairs affected by opioid dependence in Ontario over the past decade. Adverse birth outcome rates were high. Expanded services for opioid-dependent women and their children are needed.
Copyright © 2017 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Buprenorphine; methadone; neonatal abstinence syndrome; pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28343557     DOI: 10.1016/j.jogc.2016.11.009

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  13 in total

1.  Opioid use disorder in pregnancy.

Authors:  Anshula Ambasta; Mary Malebranche
Journal:  CMAJ       Date:  2019-09-23       Impact factor: 8.262

2.  Neonatal Outcomes in a Medicaid Population With Opioid Dependence.

Authors:  Susan B Brogly; Sonia Hernández-Diaz; Emily Regan; Ela Fadli; Kristen A Hahn; Martha M Werler
Journal:  Am J Epidemiol       Date:  2018-06-01       Impact factor: 4.897

3.  Relation between opioid-related harms and socioeconomic inequalities in Ontario: a population-based descriptive study.

Authors:  Zoe F Cairncross; Jeremy Herring; Trevor van Ingen; Brendan T Smith; Pamela Leece; Brian Schwartz; Karin Hohenadel
Journal:  CMAJ Open       Date:  2018-10-18

4.  Sedatives for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-05-18

5.  Long-term Healthcare Utilization by Medicaid Enrolled Children with Neonatal Abstinence Syndrome.

Authors:  Walter M Taylor; Yewei Lu; Shuang Wang; Lena S Sun; Guohua Li; Caleb Ing
Journal:  J Pediatr       Date:  2020-06       Impact factor: 6.314

6.  Educational achievement at age 9.5 years of children born to mothers maintained on methadone during pregnancy.

Authors:  Samantha J Lee; Lianne J Woodward; Jacqueline M T Henderson
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

7.  The Infant Cuddler Study: Evaluating the effectiveness of volunteer cuddling in infants with neonatal abstinence syndrome.

Authors:  Amanda Hignell; Karen Carlyle; Catherine Bishop; Mary Murphy; Teresa Valenzano; Suzanne Turner; Michael Sgro
Journal:  Paediatr Child Health       Date:  2019-10-09       Impact factor: 2.253

8.  Ischemic Placental Disease, Preterm Delivery, and Their Association With Opioid Use During Pregnancy.

Authors:  Daina B Esposito; Brian Bateman; Martha Werler; Loreen Straub; Helen Mogun; Sonia Hernandez-Diaz; Krista Huybrechts
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 5.363

9.  Opioid treatment for opioid withdrawal in newborn infants.

Authors:  Angelika Zankl; Jill Martin; Jane G Davey; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2021-07-07

10.  Need for women-centered treatment for substance use disorders: results from focus group discussions.

Authors:  Natasha Elms; Kendra Link; Adam Newman; Susan B Brogly
Journal:  Harm Reduct J       Date:  2018-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.